Cargando…

Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer

Over the last years, prostate magnetic resonance imaging (MRI) has gained a key role in the primary diagnosis of clinically significant prostate cancer (csPCa). While a negative MRI can avoid unnecessary prostate biopsies and the overdiagnosis of indolent cancers, a positive examination triggers bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cereser, Lorenzo, Evangelista, Laura, Giannarini, Gianluca, Girometti, Rossano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453091/ https://www.ncbi.nlm.nih.gov/pubmed/37627956 http://dx.doi.org/10.3390/diagnostics13162697

Ejemplares similares

Evolution of prostate MRI: from multiparametric standard to less-is-better and different-is better strategies
por: Girometti, Rossano, et al.
Publicado: (2019)

Comparison of different thresholds of PSA density for risk stratification of PI-RADSv2.1 categories on prostate MRI
por: Girometti, Rossano, et al.
Publicado: (2022)

Role of contrast-enhanced ultrasound in assessing indeterminate renal lesions and Bosniak ≥2F complex renal cysts found incidentally on CT or MRI
por: Como, Giuseppe, et al.
Publicado: (2021)

Clinical perspectives of PSMA PET/MRI for prostate cancer
por: Barbosa, Felipe de Galiza, et al.
Publicado: (2018)

Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool
por: Zattoni, Fabio, et al.
Publicado: (2023)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
por: Combes, Alexander D., et al.
Publicado: (2022)

PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?
por: Urso, Luca, et al.
Publicado: (2023)

PSMA PET imaging in the diagnosis and management of prostate cancer
por: Houshmand, Sina, et al.
Publicado: (2023)

Gross tumor volume delineation in primary prostate cancer on (18)F-PSMA-1007 PET/MRI and (68)Ga-PSMA-11 PET/MRI
por: Zhang, Yan-Nan, et al.
Publicado: (2022)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

Ga-68-PSMA PET/CT ? or PET/MRI ?, Mp-MRI ? in diagnosis and radiotherapy planning in a patient with prostate cancer
por: Cihan, Yasemin Benderli
Publicado: (2020)

PET/MRI in prostate cancer: a systematic review and meta-analysis
por: Evangelista, Laura, et al.
Publicado: (2020)

The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
por: Kase, Adam M., et al.
Publicado: (2022)

The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review
por: Lisney, Anna Rebecca, et al.
Publicado: (2022)

Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer
por: Rasul, Sazan, et al.
Publicado: (2022)

PSMA-PET in the early stages of prostate cancer
por: Barbosa, Felipe de Galiza
Publicado: (2023)

Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer
por: Kichloo, Asim, et al.
Publicado: (2020)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature
por: Colatutto, Donatella, et al.
Publicado: (2021)

Accuracy of (68)Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
por: Barbosa, Álan Roger Gomes, et al.
Publicado: (2022)

Hybrid imaging with [(68)Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
por: Glemser, P. A., et al.
Publicado: (2022)

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
por: Leung, Kevin H., et al.
Publicado: (2022)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
por: Lenzo, Nat P., et al.
Publicado: (2018)

Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET
por: Sabbagh, Ali, et al.
Publicado: (2022)

Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia
por: Cereser, Lorenzo, et al.
Publicado: (2021)

An Incidental Pancreatic Finding at 18F-Choline PET/CT: Chronic Mass-Forming Pancreatitis
por: Evangelista, Laura, et al.
Publicado: (2021)

Optimal MRI sequences for (68)Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer
por: Lake, Spencer T., et al.
Publicado: (2017)

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
por: Kwan, Timothy N., et al.
Publicado: (2021)

Irreversible electroporation for prostate cancer using PSMA PET-CT
por: Shin, Dongho, et al.
Publicado: (2023)

PSMA ligands for diagnosis and therapy of prostate cancer
por: Haberkorn, Uwe
Publicado: (2014)

PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature
por: Alongi, Pierpaolo, et al.
Publicado: (2022)

PET/CT in Prostate Cancer
por: Evangelista, Laura, et al.
Publicado: (2023)

(68)Ga-PSMA-11 PET/CT combining ADC value of MRI in the diagnosis of naive prostate cancer: Perspective of radiologist
por: Wang, Liwei, et al.
Publicado: (2020)

High-resolution computed tomography findings in humoral primary immunodeficiencies and correlation with pulmonary function tests
por: Cereser, Lorenzo, et al.
Publicado: (2018)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with (68)Ga-PSMA PET/CT Features in Primary Staging
por: Vetrone, Luigia, et al.
Publicado: (2023)

Diagnostic value of integrated (18)F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer
por: Zeng, Yuping, et al.
Publicado: (2022)

Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
por: Scobioala, Sergiu, et al.
Publicado: (2021)

Primary Staging of Prostate Cancer Patients with [(18)F]PSMA-1007 PET/CT Compared with [(68)Ga]Ga-PSMA-11 PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4qm8nrokf7f3sr3c00dvd3rdte